[What is the place of bioresorbable vascular scaffolds in setting of ST-segment elevation myocardial infarction?]

Ann Cardiol Angeiol (Paris). 2015 Dec;64(6):499-504. doi: 10.1016/j.ancard.2015.09.056. Epub 2015 Oct 21.
[Article in French]

Abstract

A 50-year-old woman was admitted for an inferior ST-segment elevation myocardial infarction; immediate coronary angiogram revealed a subocclusive stenosis of the right coronary artery. After optimal antithrombotic treatment, the type of stent could be discussed. The latest generation of drug-eluting stents showed excellent efficacy and safety in the long-term but has limitations such as potential chronic inflammation of the arterial wall and no recovery of vasoactive function. Bioresorbable vascular scaffolds, with complete resorption within several months, may reduce these limitations. Implantation of bioresorbable scaffold in the context of myocardial infarction may be interesting. However, very few studies are currently available in this setting. Preliminary results and perspectives are presented in this review.

Keywords: Absorb; Angioplastie primaire; Bioresorbable vascular scaffolds; Infarctus du myocarde; Primary Percutaneous Coronary Intervention; ST-segment elevation myocardial infarction; Stents biorésorbables.

Publication types

  • Case Reports

MeSH terms

  • Absorbable Implants
  • Angioplasty, Balloon, Coronary* / methods
  • Drug-Eluting Stents*
  • Female
  • Humans
  • Middle Aged
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / therapy*
  • Risk Factors
  • Smoking / adverse effects
  • Tissue Scaffolds*
  • Treatment Outcome